Skip to main content
. Author manuscript; available in PMC: 2015 May 23.
Published in final edited form as: Vaccine. 2014 Mar 31;32(25):3010–3018. doi: 10.1016/j.vaccine.2014.03.062

Table 1.

Properties of chimeric viruses.

Virusa (clone) C-prM junction Geneb Nucleotide change (chimeric virus numbering)b Amino acid change (individual protein numbering)b Phenotype in vero cells

Mean peak titer (log10 PFU/mL) Plaque size prior to adaptationc,d Plaque size after adaptationc
First-generation
JEV/DEN4 (CF-ME-0-13) JEV E T1465C F167S 6.0 Small Large
E A1900G K312R
E T2254C I430T
NS4B C7171T P101L
JEV/DEN4 (GG-ME-1-17) DENV-4 E G1733C Q264H 6.6 Small Large
E T2230C I430T
NS4B C7147T P101L
3′UTR 10,485 A insert N/A
JEV/DEN4 (GG-ME-2-21) WNV E A1671C M240L 6.1 Small Medium
E A2391G M480V
NS3 C5026T S158L
NS4B C7171T T105I
JEV/DEN4Δ30 (CF-ME-0-14) JEV E G1722T V253F 5.5 Small Small
NS2A A4023G M168V
NS3 G5170T R202I
NS4B T7195C V109A
NS4B C7588T A240V
JEV/DEN4Δ30 (GG-ME-1-24) DENV-4 NS3 C5014T S158L 5.6 Small Small
NS4B C7159T T105I
JEV/DEN4Δ30 (CF-ME-2-18) WNV E T2043C S364P 5.3 Small Small
E G2190A G413R
NS4B T7192C L112S
Second-generation
JEV/DEN4 (B-1a) DENV-4 prM G765A E109K 5.8 Small Small
NS3 C5014T S158L
NS4B C7159T T105I
JEV/DEN4 (C-14) DENV-4 E T2230C I430T 6.0 Small Large
NS4B C7147T P101L
JEV/DEN4 (AC-7a) DENV-4 E G1733C Q264H 6.6 Large Large
E T2230C I430T
NS4B C7147T P101L
JEV/DEN4 (D-5a) DENV-4 E A1567G K209R 6.0 Small Medium
NS4B T7180C L112S
JEV/DEN4Δ30 (B-2a) DENV-4 prM T936C Y166H 5.0 Small Small
NS3 C5014T S158L
NS4B C7159T T105I
JEV/DEN4Δ30 (D-6a) DENV-4 NS3 G4667T M42I 3.9 Small Small
NS4B T7180C L112S
a

All viruses are ME chimeric viruses (CME chimeric viruses were not viable). ME has been omitted from the virus names.

b

Engineered mutations introduced into the second generation viruses are shown in bold.

c

Plaque size was measured on day 6 post-infection: small is <1 mm, medium is 1–2 mm, and large is >2 mm. Vero-adapted rJEV India/78 (3 days post-infection) and rDEN4 produce large plaques. Vero-adapted rDENΔ30 produces medium plaques. JEV SA14-14-2 (3 days post-infection) produces small plaques.

d

Plaque size on Vero cells directly after recovery of virus and prior to terminal dilutions on Vero cells.